Used in pharmaceutical research as a key intermediate in the synthesis of protease inhibitors, particularly for the development of antiviral agents. Shows potential in the design of enzyme inhibitors targeting specific metabolic pathways in disease states. Its structure supports high selectivity and binding affinity, making it valuable in optimizing drug candidates for improved efficacy and stability. Also employed in structure-activity relationship (SAR) studies to enhance pharmacokinetic properties of therapeutic molecules.